The declining rates of hepatitis B carriage among adolescents and young people in the Eastern region of Saudi Arabia

References

1. ↵
   1. MacLachlan JH,
   2. Cowie BC

   (2015) Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med 5:a021410.

   OpenUrlAbstract/FREE Full Text
2. ↵
   1. Hope VD,
   2. Eramova I,
   3. Capurro D,
   4. Donoghoe MC

   (2014) Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect 142:270–286.

   OpenUrlCrossRef
3. ↵
   1. Alshehri A

   (2013) Hepatitis B and C viruses incidence, the risk factors of hepatocellular carcinoma, is low in Aseer Region, Saudi Arabia. Egypt Acad J Biol Sci 5:7–18.

   OpenUrl
4. 1. Aljarbou AN

   (2013) The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia. Int J Health Sci 7:333–340.

   OpenUrl
5. 1. Alqahtani JM,
   2. Abu-Eshy SA,
   3. Mahfouz AA,
   4. El-Mekki AA,
   5. Asaad AM

   (2014) Seroprevalence of hepatitis B and C virus infections among health students and health care workers in the Najran region, southwestern Saudi Arabia: The need for national guidelines for health students. BMC Public Health 14:577.

   OpenUrlCrossRefPubMed
6. 1. Al-Tawfiq JA,
   2. Anani A

   (2008) Profile of viral hepatitis A, B, and C in a Saudi Arabian hospital. Med Sci Monit 14:CR52–C56.

   OpenUrlPubMed
7. 1. Abdullah SM

   (2013) Prevalence of Hepatitis B and C in Donated Blood from the Jazan Region of Saudi Arabia. Malays J Med Sci 20:41–46.

   OpenUrl
8. 1. Alswaidi FM,
   2. O’Brien SJ

   (2010) Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors? J Epidemiol Community Health 64:989–997.

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Coppola N,
   2. De Pascalis S,
   3. Onorato L,
   4. Calò F,
   5. Sagnelli C,
   6. Sagnelli E

   (2016) Hepatitis B virus and hepatitis C virus infection in healthcare workers. World J Hepatol 8:273–281.

   OpenUrl
10. ↵
    1. Abdo AA,
    2. Sanai FM,
    3. Al-Faleh FZ

    (2012) Epidemiology of Viral Hepatitis in Saudi Arabia: Are we off the hook? Saudi J Gastroenterol 18:349–357.

    OpenUrlCrossRefPubMed
11. ↵
    1. Komatsu H

    (2014) Hepatitis B virus: Where do we stand and what is the next step for eradication? World J Gastroenterol 20:8998–9016.

    OpenUrlPubMed
12. ↵
    1. Alrowaily MA,
    2. Abolfotouh MA,
    3. Ferwanah MS

    (2008) Hepetitis B virus sero-prevalence among pregnant females in Saudi Arabia. Saudi J Gastroenterol 14:70–73.

    OpenUrl
13. ↵
    1. Abdo AA,
    2. Sanai FM

    (2015) Viral hepatitis in Saudi Arabia An unfinished story. Saudi Med J 36:785–786.

    OpenUrlFREE Full Text
14. ↵
    1. Alswaidi FM,
    2. O’brien SJ

    (2010) Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors? J Epidemiol Community Health 64:989–997.

    OpenUrlAbstract/FREE Full Text
15. ↵
    1. Al-Wayli HM

    (2009) Prevalence of hepatitis B surface antigen in a Saudi hospital population. Saudi Med J 30:448–449.

    OpenUrlPubMed
16. ↵
    1. Memish ZA,
    2. Knawy BA,
    3. El-Saed A

    (2010) Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J nfect Dis 14:e115–e120.

    OpenUrl
17. ↵
    1. Abdulmajeed AA,
    2. Rashed BA,
    3. Ali AB,
    4. Abdullah ABS,
    5. Abdulrahman SA

    (2013) Profile of viral hepatitis in Saudi Arabia. Biomedical Research 24:396–399.

    OpenUrl
18. ↵
    1. Ministry of Health

    Health Statistics Annual Book (2004-2013), Available from URL: http://www.moh.gov.sa/en/Ministry/Statistics/book/Pages/default.aspx. Update 2016; Accessed 2015 October 24.
19. ↵
    1. General Authority for Statistics

    Title of the article? Available from URL: http://www.stats.gov.sa/en/node. Update: 2016; Accessed 2015 October 25.
20. ↵
    1. Zampino R,
    2. Boemio A,
    3. Sagnelli C,
    4. Alessio L,
    5. Adinolfi LE,
    6. Sagnelli E,
    7. et al.

    (2015) Hepatitis B virus burden in developing countries. World J Gastroenterol 21:11941–11953.

    OpenUrlCrossRefPubMed
21. ↵
    1. Tsay PK,
    2. Tai DI,
    3. Chen YM,
    4. Yu CP,
    5. Wan SY,
    6. Shen YJ,
    7. et al.

    (2009) Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen. Chang Gung Med J 32:155–164.

    OpenUrlPubMed
22. ↵
    1. Abaalkhail F,
    2. Elsiesy H,
    3. AlOmair A,
    4. Alghamdi MY,
    5. Alalwan A,
    6. AlMasri N,
    7. et al.

    (2014) Saudi Association for the Study of Liver Diseases and Transplantation (SASLT). SASLT practice guidelines for the management of hepatitis B virus. Saudi J Gastroenterol 20:25–25.

    OpenUrl
23. ↵
    1. Zoulim F,
    2. Durantel D

    (2015) Antiviral therapies and prospects for a cure of chronic hepatitis B. Cold Spring Harb Perspect Med 5:a021501.

    OpenUrlAbstract/FREE Full Text
24. ↵
    1. Bagheri-Jamebozorgi M,
    2. Keshavarz J,
    3. Nemati M,
    4. Mohammadi-Hossainabad S,
    5. Rezayati MT,
    6. Nejad-Ghaderi M

    (2014) The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Hum Vaccin Immunother 10:3731–3736.

    OpenUrl
25. ↵
    1. Chang MH,
    2. You SL,
    3. Chen CJ,
    4. Liu CJ,
    5. Lee CM,
    6. Lin SM,
    7. et al.

    (2009) Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up study. Natl Cancer Inst 101:1348–1355.

    OpenUrlCrossRefPubMedWeb of Science